| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 63878 | Cytarabine Hydrochloride AZ | 6.13985294021483e-005 | 0.62342455 |
| NSC 670121 | 11-Hydroxy aclacinomycin A | 7.90190265422259e-005 | 0.330464 |
| NSC 610458 | Camptothecin Derivative | 9.44629929890654e-006 | 0.65616101 |
Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.
The detailed records of NSC 726332 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726332; 2) Community: the network communities that were significantly associated with the response to NSC 726332; 3) Molecule: the relationships between components within communities and NSC 726332; 4) MDR: the compounds that were significantly associated with the NSC 726332.
| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 63878 | Cytarabine Hydrochloride AZ | 6.13985294021483e-005 | 0.62342455 |
| NSC 670121 | 11-Hydroxy aclacinomycin A | 7.90190265422259e-005 | 0.330464 |
| NSC 610458 | Camptothecin Derivative | 9.44629929890654e-006 | 0.65616101 |